耳道念珠菌感染现状与研究进展

中国真菌学杂志　 2018, Vol. 13 　Issue (1): 53-56.

耳道念珠菌感染现状与研究进展

雷岩, 张超, 潘炜华, 廖万清

上海市医学真菌分子生物学重点实验室上海市医学真菌研究所全军真菌病重点实验室第二军医大学长征医院皮肤科, 上海 200003

收稿日期:2017-09-11 出版日期:2018-02-28 发布日期:2018-02-28
通讯作者: 张超,E-mail:zhangchao324@smmu.edu.cn;廖万清,E-mail:liaowanqing@smmu.edu.cn E-mail:zhangchao324@smmu.edu.cn;liaowanqing@smmu.edu.cn
作者简介:雷岩,男(汉族),硕士研究生在读,住院医师.E-mail:leyan_119@smmu.edu.cn
基金资助:
上海市科委项目（16DZ0500401）；上海市科委扬帆计划（17YF1425100）；国家自然基金（81471926，81720108026）；中国工程院项目（GCY）；上海市医学真菌分子生物学重点实验室项目（17DZ2272900）

Current status and research progress of Candida auris infection

LEI Yan, ZHANG Chao, PAN Wei-hua, LIAO Wan-qing

Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Institute of Medical Mycology, PLA Key Laboratory of Mycosis, Department of Dermatology and Venereology, Changzheng Hospital, Second Military Medical University, Shanghai 200003

Received:2017-09-11 Online:2018-02-28 Published:2018-02-28

摘要/Abstract

摘要：

耳道念珠菌（Candida auris）自从2009年被发现至今，已对全球性人类健康构成了严重威胁。该病原体难以用常规的表型和生物化学方法鉴定。该菌株对3种主要类型的抗真菌药物耐药，这种类型的多重耐药菌之前在其他种类的念珠菌并没有报道过。在本综述中，我们探讨了当今世界耳道念珠菌感染的现状与研究进展，希望能够引起有关学者和相关部门重视，及时制定感染预防策略和治疗方案。

关键词: 耳道念珠菌, 多重耐药菌, 致病性感染

Abstract:

Candida auris is a new type of fungus that seriously threating global human health. It's difficult to identify with conventional phenotypes and biochemical methods. The strain is resistant to three major types of antifungal agents. In this review, we discuss the present situation and research progress of Candida auris infection in the world.

Key words: Candida auris, multiple drug resistance, pathogenic infection

中图分类号:

R519.3

雷岩, 张超, 潘炜华, 廖万清. 耳道念珠菌感染现状与研究进展[J]. 中国真菌学杂志, 2018, 13(1): 53-56.

LEI Yan, ZHANG Chao, PAN Wei-hua, LIAO Wan-qing. Current status and research progress of Candida auris infection[J]. Chinese Journal of Mycology, 2018, 13(1): 53-56.

参考文献

[1] Editorial. Stop neglecting fungi[J]. Nat Microbiol, 2017,2:17120.
[2] Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital[J]. Microbiol Immunol,2009,53(1):41-44.
[3] Girard V, Mailler S, Chetry M, et al. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of fight mass spectrometry[J]. Mycoses,2016,59(8):535-538.
[4] 廖万清,张超,潘炜华.警惕"超级真菌"感染在中国的出现[J]中国真菌学杂志,2017,12(1):1-2.
[5] Kim MN, Shin JH, Sung H, et al. Candida haemulonii and closely related species at 5 university hospitals in Korea:identification, antifungal susceptibility, and clinical features[J]. Clin Infect Dis,2009,48(6):e57-e61.
[6] Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris[J]. Clin Microbiol,2011,49(9):3139-3142.
[7] Oh BJ, Shin JH, Kim MN, et al. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea[J]. Med Mycol,2011,49(1):98-102.
[8] Smita S, Shalini U. Current perspective on emergence, diagnosis and drug resistance in Candida auris[J]. Infect Drug Resist,2017,10:155-165.
[9] Sarma S, Kumar N, Sharma S, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris[J]. Indian J Med Microbiol,2013,31(1):90-101.
[10] Pan American Health Organization/World Health Organization. Epidemiological Alert:Candida auris outbreaks in health care services[R]. Washington, DC:PAHO/WHO,2016.
[11] Silke S, Ferry H, Johanna LR. First hospital outbreak of the globally emerging Candida auris in a European hospital[J]. Antimicrob Resist In,2016, 5:35.
[12] Colombia International Health Regulations[R]. Colombia International Health Regulations National Focal Point, August 26, 2016.
[13] Chowdhary A, Sharma C, Duggal S, et al. New clonal strain of Candida auris, Delhi, India[J]. Emerg Infect Dis,2013,19(10):1670-1673.
[14] Lockhart SR, Etienne KA, Vallbhaneni S, et al. Simultaneous emergence of multidrug-resistant Candida auris on three continents confirmed by whole genome sequencing and epidemiological analyses[J]. Clin Infect Dis,2017,64(2):134-140.
[15] Clancy CJ, Nguyen MH. Emergence of Candida auris:an international call to arms[J]. Clin Infect Dis, 2017,64(2):141-143.
[16] Britz E, Govender NP. Global emergence of a multi-drug resistant fungal pathogen, Candida auris[J]. S Afr J Infect Dis, 2016,31(3):69-70.
[17] Belinda C, Analy SAM, Armindo PMena, et al. First report of Candida auris in America:Clinical and microbiological aspects of 18 episodes of candidemia[J]. J Infect,2016,73(4):369-374.
[18] Sardi JCO, Pitangui NDS, Gullo FP et al. A mini review of Candida species in hospital infection:epidemiology, virulence factor and drug resistance and prophylaxis[J]. Trop Med Surg,2013, 1(5):141.
[19] Choi HI, An J, Hwang JJ, et al. Otomastoiditis caused by Candida auris:case report and literature review[J]. Mycoses,2017,60(8):488-492.
[20] Shawn RL, Kizee AE, Snigdha V, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses[J]. Clin Infect Dis,2017,64(2):134-140.
[21] Ben AR, Olshtain PK, Krieger M, et al. Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection[J]. Antimicrob Agents Ch,2012,56(5):2518-2523.
[22] Shallu K Pradeep KS, Cheshta S, et al. Multidrug-Resistant Candida auris misidentified as Candida haemulonii:characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method[J]. J Clin Microbio,2015,53(6):1823-1830.
[23] Tapia C, Batarce C. Multidrug-resistant Candida auris:‘new kid on the block’ in hospital-associated infections[J]?J Hosp Infect,2016,94(3):209-212.
[24] Ronen BA, Judith B, Ana N, et al. Multidrug resistant Candida haemulonii and C. auris, Tel Aviv, Israel[J]. Emerg Infect Dis, 2017,23(2):196-203.